VEITHsymposium™

Program (November 2023)

The program features over 1,300 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

View/Search/Print Complete 2023 Program Brochure in PDF
View/Print Entire November 2023 Program

Program Outline at a Glance

Tuesday, November 14, 2023 - Program Details

Open All Tuesday Sessions

COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS A, B AND C ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF DISEASES OF THE CORONARY ARTERIES, HEART VALVES, AND THE THORACIC AND ABDOMINAL AORTA; 6:45 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 1:	PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
SESSION 2:	PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3:	PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILIZE, AND MORE
SESSION 4:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5:	NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING
SESSION 6:	MORE ABOUT AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON THE UK NICE AAA GUIDELINES AND OTHER AORTIC PATHOLOGY
SESSION 7:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
SESSION 8:	MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
PROGRAM B (SESSIONS 9-16 - PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY AND TREATMENT OF AORTIC COARCTATION 6:40 A.M. to 5:59 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 9:	PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
SESSION 10:	NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
SESSION 11:	MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
SESSION 12:	PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
SESSION 13:	NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI) (See also Session 87)
SESSION 14:	PART 1: VASCULAR SURGERY’S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY’S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY PART 2: LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES
SESSION 15:	PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
SESSION 16:	UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
PROGRAM C-1 (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH; 7:00 A.M. to 12:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 17:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
SESSION 18:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
b>PROGRAM C-2 (SESSIONS 19-22 - INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS; 1:00 P.M. to 6:06 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 19:	HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
SESSION 20:	MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
SESSION 21:	HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
SESSION 22:	MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI)
SESSION 40:	MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT

Wednesday, November 15, 2023 - Program Details

Open All Wednesday Sessions

PROGRAMS D, E AND F ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM D (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT 6:40 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 23:	GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
SESSION 24:	NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
SESSION 25:	LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs)
SESSION 26:	NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
SESSION 27:	PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT”
SESSION 28:	NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
SESSION 29:	LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
SESSION 30:	NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
PROGRAM E (SESSIONS 31-38 - NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI- ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE; 6:40 A.M. to 5:32 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 31:	ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
SESSION 32:	CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
SESSION 33:	PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
SESSION 34:	TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
SESSION 35:	RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
SESSION 36:	ISSUES IMPORTANT IN VASCULAR SURGERY: PRACTICE PATTERNS, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
SESSION 37:	MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
SESSION 38:	UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTs: THE FDA: STAISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
PROGRAM F (SESSIONS 39-46 - MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC AND CAROTID TOPICS; 6:50 A.M. to 6:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 39:	MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
SESSION 41:	OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
SESSION 42:	PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
SESSION 43:	MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
SESSION 44:	MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
SESSION 45:	HOT AORTIC TOPICS
SESSION 46:	MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS

Thursday, November 16, 2023 - Program Details

Open All Thursday Sessions

PROGRAMS G, H AND I AND J ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM G (SESSIONS 47-54 - EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY; 6:50 A.M. to 5:52 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 47:	EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS, THE ROLE OF MAJOR FOUNDATIONS
SESSION 48:	PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 49:	MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 50:	A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
SESSION 51:	PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
SESSION 52:	MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 53:	EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
SESSION 54:	PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
PROGRAM H (SESSIONS 55-63 - NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS; 6:50 A.M. to 5:52 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 55:	NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR
SESSION 56:	NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR; ENDOGRAFTS FOR TREATMENT OF CONNECTIVE TISSUE DISORDERS
SESSION 57:	NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
SESSION 58:	NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS
SESSION 59:	NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28), PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH
SESSION 60:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 61:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
SESSION 62:	NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
SESSION 63:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
PROGRAM I (SESSIONS 64-71 - SUPERFICIAL VENOUS DISEASE; 7:00 A.M. to x:xx P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 64:	PROGRAM TO BE DETERMINED
PROGRAM J (SESSIONS 72-75 - MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT; 8:00 A.M. to xxx P.M.) Location: Murray Hill Suites, 2nd Floor
SESSION 72:	PROGRAM TO BE DETERMINED

Special Non-CME Accredited Activities

Past Programs

2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 |
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
2007 | 2006 | 2005